SEARCH
Want an open regulatory environment & less pressure on drug pricing, says Cipla
CNBC-TV18
2019-04-11
Views
218
Description
Share / Embed
Download This Video
Report
In her first ever television interview, Samina Vaziralli, the executive vice chairperson of Cipla and Umang Vohra, global CEO and MD talk about the pharma company's election wishlist and legacy issues that plague the organisation.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x75nhfk" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
02:50
Seeing pricing pressure in US due to quick approvals, says Cipla
00:16
The Price of Global Health Drug Pricing Strategies to Balance Patient Access and the Funding of Innovation
00:24
[PDF] The Price of Global Health: Drug Pricing Strategies to Balance Patient Access and the
04:44
Cadila on pricing pressure in US
05:33
Pricing Pressure To Continue For Next 2 Years, Says Lupin's Nilesh Gupta
04:47
Pricing Pressure Eases In The U.S.
05:15
Dollar Retreat May Cause Pricing Pressure Going Forward: JK Paper
02:18
Pricing Pressure May Hurt Lupin's Margin
07:39
Care Ratings Expects Pricing Pressure To Reduce Going Forward
09:51
Pricing Pressure Kicking In For AkzoNobel? | NDTV Profit
03:05
UK farmers predict empty shelves as they call on help from supermarket bosses with pricing pressure
00:22
The Drug Regulatory Authority issued a new list of medicine prices